Atagabalin

Atagabalin
Clinical data
ATC code	none;
Identifiers
	IUPAC name [(3S,4S)-1-(aminomethyl)-3,4-dimethylcyclopentyl]acetic acid;
CAS Number	223445-75-8 ;
PubChem CID	9794485;
ChemSpider	7970252 ;
UNII	JT7957Q2FB;
ChEMBL	ChEMBL593430 ;
CompTox Dashboard (EPA)	DTXSID80944993 ;
Chemical and physical data
Formula	C10H19NO2
Molar mass	185.267 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@H]1CC(C[C@@H]1C)(CC(=O)O)CN;
	InChI InChI=1S/C10H19NO2/c1-7-3-10(6-11,4-8(7)2)5-9(12)13/h7-8H,3-6,11H2,1-2H3,(H,12,13)/t7-,8-/m0/s1 ; Key:IUVMAUQEZFTTFB-YUMQZZPRSA-N ;
	(what is this?) (verify)

Atagabalin (PD-0200,390) is a drug developed by Pfizer and related to gabapentin, which similarly binds to the α₂δ calcium channels (1 and 2). It was under development as a treatment for insomnia, but was discontinued following unsatisfactory trial results.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.